Anal Fissure Treatment Market Research Report: Information, by Treatment Type (Medication and Surgery), Route of Administration (Oral and Topical), End User (Hospitals & Clinics and Research & Academic institutes) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
ID: MRFR/Pharma/2553-CR | August 2019 | Region: Global | 101 pages
The Anal Fissure Treatment Market is expected to register 7.6% CAGR and is expected to reach USD 2,526.5 Million by 2023.
An anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The prominent factors that drive the market growth are growing incidences of constipation, a rapidly growing aging population, and increasing adoption of an unhealthy lifestyle. However, the popularity of over the counter (OTD) drugs and alternative treatment therapies for anal fissure are likely to restrain the market growth over the forecast period.
Market Dynamics
Constipation is a condition where the individual might have stools that are difficult or painful to pass being hard, dry, or lumpy. However, long-lasting constipation may have complications, such as hemorrhoids, anal fissures, rectal prolapse, and others. According to a recent survey by the American Gastroenterological Association, 16% of Americans suffer from chronic constipation, and nearly 33% over the age of 60 experience the condition. This leads to almost 6 million visits to the doctors’ offices or clinics and nearly 700,000 visits to emergency rooms every year.
Furthermore, according to the survey conducted by IPSOS, a market research firm, and Abbott India in 2018, 22% of the adult Indian population suffer from constipation, with 13% complaining of severe constipation. However, when the same survey was conducted by Abbott India and IPSOS in 2015, which found that 14% people in urban India suffer from chronic constipation and incidents of chronic constipation was over 10% worldwide. Thus, the growing incidences of constipation related problems worldwide are driving the growth of anal fissure treatment market.
Anal Fissure Treatment Market Revenue, by Treatment, 2017 (USD Million) 
Sources: MRFR Analysis
Segmentation
The anal fissure treatment market is segmented into treatment type, route of administration, end user, and region.
Based on treatment, the anal fissure treatment market is divided into medication and surgery. The medication segment is further segmented into stool softeners, laxatives, anesthetics and steroids, nitroglycerin, calcium channel blocking drugs, and botulinum toxin. Topical agents such as nitroglycerin ointments or calcium channel blockers including diltiazem or nifedipine that relax the internal anal sphincter and increase blood flow to the affected area have been proven in randomized placebo-controlled trials to be effective in reducing the healing time with success rates.
Based on route of administration, the global market is divided in to oral and topical. In oral administration, the medicine or drug is taken through the mouth. The oral treatment methods for anal fissure include pain-relieving drugs and calcium channel blockers, which include LOMOTIL and Tribenzo drugs. Companies such as Teva Pharmaceutical Industries Ltd, Pfizer Inc., and Allergan Inc. offer oral drugs for anal fissure treatment.
Based on end user, the global market is divided into Hospitals & Clinics and Research & Academic institutes. The hospitals & clinics segment held the largest market share in the anal fissure treatment market in 2017. The increasing number of patients with diarrhea, constipation, and Crohn's disease is expected to drive this segment in the global market during the forecast period.
Anal Fissure Treatment Market Share, by Region, 2017 (%) 
Sources: MRFR Analysis
Regional Analysis
Based on region, the anal fissure treatment market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to reach USD 1,000.6 million by 2023 with 7.8% CAGR from 2018 to 2023. The region accounts for the largest regional market owing to the growing geriatric population, childbirth trauma in women, increasing Crohn's disease, and ulcerative colitis among the population. According to the Centers for Disease Control and Prevention, it was estimated that three million adults in the US were reported to be diagnosed with inflammatory bowel disease in 2015. The growing inflammatory bowel disease in the Americas is likely to increase the demand for anal fissure treatment in this region.
Europe is anticipated to hold the second-largest market for anal fissure treatment during the forecast period. The increasing consumption of fast food and improper eating habits are creating intestinal problems in the population. Additionally, some food allergies are also responsible for causing immune system problems, diarrhea or chronic constipation that would increase the demand for anal fissure treatment products. According to the United Nations International Children's Emergency Fund (UNICEF) data, worldwide 480,000 young children are dying every year due to diarrhea. The increasing prevalence of diarrhea among children may increase the demand for anal fissure treatment.
The presence of several major pharmaceutical and biotech companies in Asia-Pacific that are introducing new products and treatment methods for anal fissure treatment is expected to boost the market in the region during the forecast period.
The Middle East & Africa holds the least market share. Factors such as rising health problems including frequent diarrhea or chronic constipation caused due to poor nutrition support and consumption of contaminated drinking water are causing anal fissures among the population. The increasing awareness about treatments and products for treating an anal fissure is expected to boost the market growth in the region during the forecast period.
Key Players
Pfizer Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Cook, Cigna, Eisai Co. Ltd, Abbott Laboratories, Bayer AG, AstraZeneca, Allergan Inc., Valeant Pharmaceuticals International Inc., and Taro Pharmaceutical Industries Ltd are some of the major players operating in the anal fissure treatment market.
The players operating in the anal fissure treatment market are focusing on product launches, along with expanding their global footprints by entering untapped markets.
Market Segmentation
Anal Fissure Treatment Market, by Treatment Type
- Medication
- Surgery
Anal Fissure Treatment Market, by Routes of Administration
- Oral
- Topical
Anal Fissure Treatment Market, by End User
- Hospitals & Clinics
- Research & Academic institutes
Anal Fissure Treatment Market, by Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia & New Zealand
- Southeast Asia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- South America
Intended Audience
- Medical research laboratories
- Medical device manufacturers
- Research and development (R&D) companies
- Market research and consulting service providers
- Potential investors
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 2,526.5 Million |
| CAGR | 7.6% (2018-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Treatment Type, Route of Administration, End User and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Pfizer Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Cook, Cigna, Eisai Co. Ltd, Abbott Laboratories, Bayer AG, AstraZeneca, Allergan Inc., Valeant Pharmaceuticals International Inc., and Taro Pharmaceutical Industries Ltd |
| Key Market Opportunities | Joint ventures, strategic alliances, mergers and acquisitions, new product developments |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Anal fissure treatment market projected to grow at approximately 7.6% CAGR during the assessment period (2018-2023).
The valuation of the global anal fissure treatment market is estimated to increase to USD 2,526.5 MN by the end of 2023.
Advances in technology and the availability of various treatment options are major tailwinds pushing the growth of the global anal fissure treatment market.
North America holds the largest share in the global anal fissure treatment market, followed by Europe and the Asia Pacific, respectively.
Abbott Laboratories (U.S.), AstraZeneca (U.K.), Pfizer Inc. (U.S.), Eisai Co. Ltd. (Japan), GlaxoSmithKline Plc (U.K.), Cigna (U.S.), Taro Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Allergan Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Valeant Pharmaceuticals International Inc. (Canada), and Cook (U.S.), are some of the top players operating in the global anal fissure treatment market.
Anal Fissure Treatment Market – Report Summary
Global anal fissure treatment market to post a compound annual growth rate of 7.6% during the forecast period (2018-2023). The incidence rate has increased to a significant extent in recent years. The expanding patient population is driving the demand for anal fissure treatment. The onset of anal fissure is primarily linked with conditions such as constipation, diarrhea, Crohn's disease etc. Fissure could be a minor or major tear in the mucosal lining of the distal anal canal below the dentate line. Unhealthy eating habits and constipation are some of the factors associated with anal fissure.
There is a strong demand for anal fissure medication. The condition occurs in both minors and adults. Various over-the-counter medicines for anal fissure have come up in recent years. At the same time, alternative treatment therapies are available as well. The rising geriatric population is expected to reflect favorably on the global anal fissure treatment market during the forecast period. ¬Strain while passing the stool is a common issue in elderly population, this often result in anal fissure. Elderly people and infants are more susceptible to such conditions owing to the higher fragility. Currently, over-the-counter medications are witnessing a strong demand as most individuals are inclined towards such convenient options. Topical nitroglycerin and calcium channel blockers such as nifedipine and diltiazem are the first line of treatment for symptomatic anal fissure.
Segmental Analysis
Segmental analysis of the global anal fissure treatment market has been conducted on the basis of treatment type, route of administration, end user and region.
By treatment type, the market has been segmented into medications and surgery. The medication segment is further segmented into stool softeners, laxatives, anesthetics and steroids, nitroglycerin, calcium channel blocking drugs, and botulinum toxin. Currently, the medication segment accounts of the largest market share in terms of value. In 2017, the segment accounted for more than two-third share of the market and is set to exhibit a CAGR of 7.68% during the forecast period.
On the basis of administration, the market has been segmented into oral, topical and others. The oral segment is expected to remain highly lucrative during the forecast period. The segment accounted for 78.35% share of the market in 2017 and is expected to reach USD 2,004.2 Mn by 2023, reflecting a healthy CAGR. Some of the common oral treatment methods for anal fissure include pain-relieving drugs and calcium channel blockers namely LOMOTIL and Tribenzo drugs.
Based on end user, the market has been segmented into hospitals and clinics, academic and research institutes, and others. In terms of value, the hospitals and clinics segment accounts for the lion’s share of the market. This is primarily attributed to factors such as growing patient influx in hospitals and rapid development of healthcare infrastructure in developing countries. Towards the end of the assessment period, the healthcare and clinic segment is likely to reach a market valuation of USD 1,717.1 Mn by 2023.
Regional Analysis
On the basis of region, the global anal fissure market has been segmented into Americas, Europe, Asia-Pacific, and the Middle East and Africa. Of these, the market in Americas is highly attractive. During the forecast period, the market in the region is expected to surge at 7.8% CAGR to reach a valuation of over 1,000 Mn. Growing geriatric population, strong healthcare penetration and increased prevalence of associated disorders such as Crohn's disease, inflammatory bowel disease and ulcerative colitis is are factors influencing the incidence rate in countries such as the U.S, Canada, Mexico and Brazil.
Meanwhile, Europe holds the second spot and is likely to retain its position over the forecast period. Existence of robust healthcare facilities, especially in West Europe coupled with the high healthcare expenditure supports the growth of the market in the region. Also, the region geriatric population in many of the European countries such as the U.K., France, Germany, among others is influencing the incidence rate in Europe. Asia Pacific is also emerging as a significant market for anal fissure treatment. High rate of diarrhea, consumption of unhealthy food and improving healthcare penetration of healthcare are some of factors influence the market’s growth in the region. The market is Asia-Pacific is expected to register a CAGR of 7.9% during the forecast period. Many of the global pharmaceutical and biotech companies are expanding their operations in APAC in order to tap into lucrative opportunities present in the region.
Competition Tracking
Prominent players in the anal fissure treatment market report include GlaxoSmithKline Plc (U.K.), Valeant Pharmaceuticals International Inc (Canada), Cigna (U.S.), Allergan Inc. (U.S.), Eisai Co. Ltd. (Japan), Abbott Laboratories (U.S.), AstraZeneca (U.K.), Cook (U.S.), Pfizer Inc. (U.S.), Taro Pharmaceutical Industries Ltd. (Israel), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), and others.
1 Report Prologue
2 Market Introduction
2.1 Scope of Study 14
2.2 Research Objective 14
2.3 List of Assumptions 14
3 Research Methodology
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 19
3.4 Market Size Estimation 20
4 Market Dynamic
4.1 Introduction 22
4.2 Drivers 23
4.2.1 Increasing Pediatric and Geriatric Population 23
4.2.2 Growing Incidences of Constipation 23
4.2.3 Increasing Adoption of Unhealthy Lifestyle 23
4.2.4 Popularity of Over-the-Counter (OTD) Drugs 23
4.3 Restraints 24
4.3.1 Alternate Treatment Therapies 24
4.3.2 Declining Reimbursements 24
4.4 Opportunities 24
4.4.1 Entering Untapped Markets 24
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis 26
5.1.1 Bargaining Power of Suppliers 26
5.1.2 Bargaining Power of Buyers 27
5.1.3 Threat of New Entrants 27
5.1.4 Threat of Substitutes 27
5.1.5 Intensity of Rivalry 27
5.2 Value Chain Analysis 28
5.2.1 Primary Activities 28
5.2.2 Secondary Activities 28
6 Anal Fissure Treatment Market, by Treatment Type
6.1 Introduction 30
6.2 Medication 31
6.3 Surgery 32
7 Anal Fissure Treatment Market, by Route of Administration
7.1 Introduction 34
7.2 Oral 35
7.3 Topical 36
8 Anal Fissure Treatment Market, by End User
8.1 Introduction 38
8.2 Hospitals & Clinics 39
8.3 Research & Academic institutes 39
9 Global Anal Fissure Treatment Market, by Region
9.1 Introduction 41
9.2 Americas 43
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.1 North America 45
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.1.1 US 47
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.1.2 Canada 48
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.2 South America 49
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3 Europe 50
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1 Western Europe 52
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.1 Germany 54
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.2 UK 55
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.3 France 56
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.4 Italy 57
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.5 Spain 58
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.6 Rest of Western Europe 59
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.2 Eastern Europe 60
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4 Asia-Pacific 62
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.1 Japan 64
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.2 China 65
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.3 India 66
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.4 Australia 67
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.5 South Korea 68
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.6 Rest of Asia-Pacific 69
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.5 Rest of the World 71
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
10 Competitive Landscape
10.1 Introduction 73
11 Company Profiles
11.1 Pfizer Inc. 75
11.1.1 Company Overview 75
11.1.2 Financial Overview 75
11.1.3 Products/Services Offered 76
11.1.4 Key Developments 76
11.1.5 SWOT Analysis 76
11.1.6 Key Strategies 76
11.2 Teva Pharmaceutical Industries Ltd 77
11.2.1 Company Overview 77
11.2.2 Financial Overview 77
11.2.3 Products/Services Offered 78
11.2.4 Key Developments 78
11.2.5 SWOT Analysis 78
11.2.6 Key Strategies 78
11.3 GlaxoSmithKline Plc 79
11.3.1 Company Overview 79
11.3.2 Financial Overview 79
11.3.3 Products/Services Offered 80
11.3.4 Key Developments 80
11.3.5 SWOT Analysis 80
11.3.6 Key Strategies 80
11.4 Cook 81
11.4.1 Company Overview 81
11.4.2 Financial Overview 81
11.4.3 Products/Services Offered 81
11.4.4 SWOT Analysis 81
11.4.5 Key Developments 81
11.4.6 Key Strategies 81
11.5 Cigna 82
11.5.1 Company Overview 82
11.5.2 Financial Overview 82
11.5.3 Products/Services Offered 83
11.5.4 SWOT Analysis 83
11.5.5 Key Developments 83
11.5.6 Key strategy 83
11.6 Eisai Co. Ltd. 84
11.6.1 Company Overview 84
11.6.2 Financial Overview 84
11.6.3 Products/Services Offered 85
11.6.4 Key Developments 85
11.6.5 SWOT Analysis 85
11.6.6 Key Strategies 85
11.7 Abbott Laboratories 86
11.7.1 Company Overview 86
11.7.2 Financial Overview 86
11.7.3 Products/Services Offered 87
11.7.4 Key Developments 87
11.7.5 SWOT Analysis 87
11.7.6 Key strategy 88
11.8 Bayer AG 89
11.8.1 Company Overview 89
11.8.2 Financial Overview 89
11.8.3 Products/Services Offered 90
11.8.4 Key Developments 90
11.8.5 SWOT Analysis 90
11.8.6 Key Strategies 90
11.9 AstraZeneca 91
11.9.1 Company Overview 91
11.9.2 Financial Overview 91
11.9.3 Products/Services Offered 92
11.9.4 Key Developments 92
11.9.5 SWOT Analysis 92
11.9.6 Key Strategies 92
11.10 Allergan Inc. 93
11.10.1 Company Overview 93
11.10.2 Financial Overview 93
11.10.3 Products/Services Offered 94
11.10.4 Key Developments 94
11.10.5 SWOT Analysis 94
11.10.6 Key Strategies 94
11.11 Valeant Pharmaceuticals International Inc. 95
11.11.1 Company Overview 95
11.11.2 Financial Overview 95
11.11.3 Products/Services Offered 96
11.11.4 Key Developments 96
11.11.5 SWOT Analysis 96
11.11.6 Key Strategies 96
11.12 Taro Pharmaceutical Industries Ltd 97
11.12.1 Company Overview 97
11.12.2 Financial Overview 97
11.12.3 Products/Services Offered 98
11.12.4 Key Developments 98
11.12.5 SWOT Analysis 98
11.12.6 Key Strategies 98
12 Appendix
12.1 Discussion Blue Print 100
13 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 14
TABLE 2 PRIMARY INTERVIEWS 17
TABLE 3 GLOBAL ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 30
TABLE 4 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR MEDICATION 2020–2027 (USD MILLION) 31
TABLE 5 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR SURGERY 2020–2027 (USD MILLION) 32
TABLE 6 GLOBAL ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 34
TABLE 7 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR ORAL 2020–2027 (USD MILLION) 35
TABLE 8 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR TOPICAL 2020–2027 (USD MILLION) 36
TABLE 9 GLOBAL ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 38
TABLE 10 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR HOSPITALS & CLINICS 2020–2027 (USD MILLION) 39
TABLE 11 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR HOSPITALS & CLINICS 2020–2027 (USD MILLION) 39
TABLE 12 GLOBAL ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 41
TABLE 13 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 43
TABLE 14 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 43
TABLE 15 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 44
TABLE 16 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 44
TABLE 17 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY COUNTRY 2020–2027 (USD MILLION) 45
TABLE 18 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 45
TABLE 19 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 46
TABLE 20 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 46
TABLE 21 US ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 47
TABLE 22 US: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 47
TABLE 23 US: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 47
TABLE 24 CANADA ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 48
TABLE 25 CANADA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 48
TABLE 26 CANADA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 48
TABLE 27 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 49
TABLE 28 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 49
TABLE 29 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 49
TABLE 30 EUROPE: ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 50
TABLE 31 EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 50
TABLE 32 EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 51
TABLE 33 EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 51
TABLE 34 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY COUNTRY/REGION 2020–2027 (USD MILLION) 52
TABLE 35 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 53
TABLE 36 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 53
TABLE 37 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 53
TABLE 38 GERMANY: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 54
TABLE 39 GERMANY: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 54
TABLE 40 GERMANY: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 54
TABLE 41 UK: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 55
TABLE 42 UK: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 55
TABLE 43 UK: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 55
TABLE 44 FRANCE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 56
TABLE 45 FRANCE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 56
TABLE 46 FRANCE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 56
TABLE 47 ITALY: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 57
TABLE 48 ITALY: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 57
TABLE 49 ITALY: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 57
TABLE 50 SPAIN: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 58
TABLE 51 SPAIN: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 58
TABLE 52 SPAIN: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 58
TABLE 53 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 59
TABLE 54 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
2020–2027 (USD MILLION) 59
TABLE 55 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 60
TABLE 56 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 60
TABLE 57 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 60
TABLE 58 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 61
TABLE 59 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY COUNTRY/REGION 2020–2027 (USD MILLION) 62
TABLE 60 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 63
TABLE 61 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 63
TABLE 62 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 63
TABLE 63 JAPAN: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 64
TABLE 64 JAPAN: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 64
TABLE 65 JAPAN: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 64
TABLE 66 CHINA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 65
TABLE 67 CHINA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 65
TABLE 68 CHINA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 65
TABLE 69 INDIA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 66
TABLE 70 INDIA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 66
TABLE 71 INDIA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 66
TABLE 72 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 67
TABLE 73 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 67
TABLE 74 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 67
TABLE 75 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 68
TABLE 76 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 68
TABLE 77 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 68
TABLE 78 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 69
TABLE 79 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 69
TABLE 80 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 70
TABLE 81 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 71
TABLE 82 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 71
TABLE 83 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 71
TABLE 84 TOP PLAYERS IN THE GLOBAL ANAL FISSURE TREATMENT MARKET 73
14 List of Figures
FIGURE 1 GLOBAL ANAL FISSURE TREATMENT MARKET: MARKET STRUCTURE 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 20
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ANAL FISSURE TREATMENT MARKET 22
FIGURE 5 VALUE CHAIN 28
FIGURE 6 GLOBAL ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020 & 2027 (USD MILLION) 31
FIGURE 7 GLOBAL ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020 & 2027 (USD MILLION) 35
FIGURE 8 GLOBAL ANAL FISSURE TREATMENT MARKET, BY END USER 2020 & 2027 (USD MILLION) 38
FIGURE 9 GLOBAL ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 42
FIGURE 10 AMERICAS: ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 43
FIGURE 11 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY 2020 (%) 45
FIGURE 12 EUROPE: ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 50
FIGURE 13 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY/REGION 2020 (%) 52
FIGURE 14 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY/REGION 2020 (%) 62
Global Anal Fissure Treatment Market: Competitive Landscape
The global anal fissure treatment market is characterized by the presence of many global, regional, and local players. The market is competitive with all players competing to gain a presence in the market. Intense competition, rapid advances in technology, frequent changes in government policies, and regulations are key factors that confront market growth. The manufacturers compete based on cost, quality, and reliability. It is decisive for manufacturers to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.
The growth of market players is dependent on market conditions, government support, and industry development. Thus, manufacturers should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that the improvement of the global economic scenario combined with efforts to enhance the infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and increase the global market share.
The players with better technical and financial resources could develop innovative products. Further, research and development would play a major role in the development of players in the market. Therefore, manufacturers must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their products and services in the market.